StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Friday. The brokerage issued a hold rating on the stock.
China Pharma Trading Down 3.7 %
Shares of China Pharma stock opened at $0.24 on Friday. The business’s fifty day moving average price is $0.21 and its two-hundred day moving average price is $0.27. The company has a quick ratio of 0.24, a current ratio of 0.84 and a debt-to-equity ratio of 0.19. China Pharma has a 1-year low of $0.17 and a 1-year high of $1.21.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- How to Invest in Small Cap Stocks
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- What is Insider Trading? What You Can Learn from Insider Trading
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
